CDW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CDW is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is near a key pivot, the technical setup is only mildly constructive, and the next earnings report is very close, which makes the near-term setup less attractive for an impatient buyer. The business fundamentals are improving, but Wall Street is still mostly Neutral/Equal Weight overall, and there is no strong proprietary buy signal today. Best direct call: hold and wait for a better entry or clearer earnings confirmation.
CDW's price is 136.36, slightly below the prior close of 136.91, and near the pivot level of 137.11. The MACD histogram is positive at 0.0246 but contracting, which suggests momentum is weakening rather than accelerating. RSI_6 at 61.0 is neutral-to-mildly bullish, not overbought but also not a clear breakout signal. Moving averages are converging, which usually signals a neutral consolidation phase. Support is visible at 132.35 and 129.41, while resistance stands at 141.86 and 144.80. Overall trend: sideways to slightly constructive, but not strong enough to justify an aggressive buy today.
["Q4 2025 revenue rose 6.27% YoY.", "Q4 2025 net income rose 5.79% YoY and EPS rose 8.63% YoY.", "Gross margin improved to 22.76%, up 2.15% YoY.", "JPMorgan placed CDW on positive catalyst watch and sees AI infrastructure spending as a potential upside driver.", "UBS still has a Buy rating and said estimates may have bottomed.", "Small business and education growth were highlighted as strengths in the latest analyst commentary."]
["No news in the recent week, so there is no fresh catalyst driving the stock now.", "Most recent analyst ratings are still Neutral or Equal Weight overall, which limits conviction.", "Several firms lowered price targets in February, including JPMorgan, Citi, UBS, and Barclays versus prior levels.", "Option flow is skewed toward puts on a volume basis, suggesting cautious sentiment.", "Earnings are scheduled for 2026-05-06, creating near-term uncertainty before results.", "Pattern-based trend estimates suggest negative near-term performance over the next day, week, and month."]
In the latest reported quarter, Q4 2025, CDW showed steady operational improvement. Revenue increased to $5.511 billion, up 6.27% YoY. Net income rose 5.79% YoY to $279.5 million, EPS increased 8.63% YoY to $2.14, and gross margin expanded to 22.76%. This is a healthy growth profile, but not an explosive one, and the market appears to be waiting for stronger evidence of sustained acceleration.
Analyst sentiment is mixed to neutral. JPMorgan recently placed CDW on positive catalyst watch while keeping a Neutral rating and $160 target. Citi raised its target to $150 and kept Neutral. UBS cut its target to $162 from $190 but kept Buy, saying estimates may have bottomed. Barclays lowered its target to $144 and kept Equal Weight, noting strength in small business and education but weakness in corporate and federal demand. Overall, Wall Street sees decent fundamentals but not a compelling upside case yet.
